267 related articles for article (PubMed ID: 34301306)
1. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
2. Clinical Value of
Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
Front Immunol; 2021; 12():745211. PubMed ID: 34867971
[TBL] [Abstract][Full Text] [Related]
3. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
4. Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Liu Y; Wang G; Wang H; Zhao X; Chen D; Su X; Yan J; Liang J; Lin J; Zhao K
Clin Rheumatol; 2022 Jul; 41(7):2103-2112. PubMed ID: 35305186
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
6. FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study.
Kastrati K; Nakuz TS; Kulterer OC; Geßl I; Simader E; Mrak D; Bonelli M; Kiener HP; Prayer F; Prosch H; Aletaha D; Langsteger W; Traub-Weidinger T; Blüml S; Lechner-Radner H; Hacker M; Mandl P
EClinicalMedicine; 2024 Jun; 72():102598. PubMed ID: 38633577
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
9. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
10. Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study.
Liang J; Cao H; Ke Y; Sun C; Chen W; Lin J
Front Med (Lausanne); 2020; 7():12. PubMed ID: 32083087
[No Abstract] [Full Text] [Related]
11. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
12. Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study.
Liang J; Cao H; Yang Y; Ke Y; Yu Y; Sun C; Yue L; Lin J
Front Med (Lausanne); 2021; 8():626953. PubMed ID: 33614683
[No Abstract] [Full Text] [Related]
13. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
14. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
15. [The prediction of disease progression by
Zhao Z; Li KP; Wang YY; Pei L; Guan ZW; Jin JY; Zhu J; Zhang JL; Huang F
Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):661-664. PubMed ID: 34619844
[TBL] [Abstract][Full Text] [Related]
16. Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients.
Li Y; Gao X; Li Y; Jia X; Zhang X; Xu Y; Gan Y; Li S; Chen R; He J; Sun X
Front Med (Lausanne); 2020; 7():363. PubMed ID: 32850886
[No Abstract] [Full Text] [Related]
17. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through Semiquantitative and Quantitative Analysis of Lung Computed Tomography.
Roncella C; Barsotti S; Valentini A; Cavagna L; Castellana R; Cioffi E; Tripoli A; Zanframundo G; Biglia A; Bartholmai B; De Liperi A; Mosca M; Romei C
J Thorac Imaging; 2022 Sep; 37(5):344-351. PubMed ID: 35576535
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
20. Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease.
Chen F; Jin Q; Zhang Y; Wang G; Li G; Shu X
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
